Cargando…

Comorbidities in Anti-Cyclic Citrullinated Peptide Positive At-Risk Individuals Do Not Differ from Those Patients with Early Inflammatory Arthritis

OBJECTIVES: To compare comorbidities in a cohort of cyclic citrullinated peptide (CCP) antibody positive patients without or prior to onset of inflammatory arthritis (IA) to those in patients with early IA. METHODS: Baseline data from two established cohorts were used. The first recruited people at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Twigg, Sarah, Nikiphorou, Elena, Nam, Jackie L., Hunt, Laura, Mankia, Kulveer, Pentony, Peta Elizabeth, Freeston, Jane E., Tan, Ai Lyn, Emery, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825886/ https://www.ncbi.nlm.nih.gov/pubmed/29516000 http://dx.doi.org/10.3389/fmed.2018.00035

Ejemplares similares

Prevalence of Periodontal Disease and Periodontopathic Bacteria in Anti–Cyclic Citrullinated Protein Antibody–Positive At-Risk Adults Without Arthritis
por: Mankia, Kulveer, et al.
Publicado: (2019)

The Role of Ultrasound Across the Inflammatory Arthritis Continuum: Focus on “At-Risk” Individuals
por: Duquenne, Laurence, et al.
Publicado: (2020)

What Is the Value of Ultrasound in Individuals ‘At-Risk’ of Rheumatoid Arthritis Who Do Not Have Clinical Synovitis?
por: Di Matteo, Andrea, et al.
Publicado: (2021)

Does periodontal treatment improve rheumatoid arthritis disease activity? A systematic review
por: Mustufvi, Zhain, et al.
Publicado: (2022)

When and how should we use imaging in individuals at risk of rheumatoid arthritis?
por: Harnden, Kate, et al.
Publicado: (2022)

The Role of the Microbiome in Driving RA-Related Autoimmunity
por: Rooney, Cristopher M., et al.
Publicado: (2020)

Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis
por: Abdel Fattah, Nermeen SA, et al.
Publicado: (2009)

Opportunities and challenges in early diagnosis of rheumatoid arthritis in general practice
por: Siddle, Heidi J, et al.
Publicado: (2023)

Should We Be Screening for and Treating Periodontal Disease in Individuals Who Are at Risk of Rheumatoid Arthritis?
por: Mustufvi, Zhain, et al.
Publicado: (2021)

The Role of Musculoskeletal Ultrasound in the Rheumatoid Arthritis Continuum
por: Di Matteo, Andrea, et al.
Publicado: (2020)

Pathogenic Role of Circulating Citrullinated Antigens and Anti-Cyclic Monoclonal Citrullinated Peptide Antibodies in Rheumatoid Arthritis
por: Won, Pureun, et al.
Publicado: (2021)

Antibodies to leukotoxin A from the periodontal pathogen Aggregatibacter actinomycetemcomitans in patients at an increased risk of rheumatoid arthritis
por: Martinsson, Klara, et al.
Publicado: (2023)

A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis
por: Mankia, Kulveer, et al.
Publicado: (2021)

Anti-cyclic citrullinated peptide antibodies in children with Juvenile Idiopathic Arthritis
por: Hamooda, Mohamed, et al.
Publicado: (2016)

Ultrasound subclinical synovitis in anti-CCP-positive at-risk individuals with musculoskeletal symptoms: an important and predictable stage in the rheumatoid arthritis continuum
por: Di Matteo, Andrea, et al.
Publicado: (2021)

Anti-cyclic citrullinated peptide antibody predicts the development of rheumatoid arthritis in patients with undifferentiated arthritis
por: Li, Chun, et al.
Publicado: (2019)

Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
por: Tebo, Anne E, et al.
Publicado: (2012)

Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
por: El-Banna, Hassan, et al.
Publicado: (2014)

Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies
por: Vignesh, Ammapati Paul Pandian, et al.
Publicado: (2015)

Anti-Cyclic Citrullinated Peptide Antibody and Periodontal Status in Rheumatoid Arthritis Patients
por: Mohamad, Wan Majdiah Wan, et al.
Publicado: (2018)

Anti–Cyclic Citrullinated Peptide Antibody as a Predictor of Rheumathoid Arthritis Complications
por: Mekic, Mevludin, et al.
Publicado: (2020)

Salivary anti-cyclic citrullinated peptide as a screening tool for rheumatoid arthritis
por: Mortazavi, Nazanin, et al.
Publicado: (2022)

Benefit of early treatment in inflammatory polyarthritis patients with anti–cyclic citrullinated peptide antibodies versus those without antibodies
por: Farragher, Tracey M, et al.
Publicado: (2010)

Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
por: Alexiou, Ioannis, et al.
Publicado: (2007)

Clinical significance of anti-cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis
por: Bo, Li, et al.
Publicado: (2008)

Anti-keratin and anti-cyclic citrullinated peptide autoantibodies in patients with juvenile idiopathic arthritis
por: Vavrinec, J, et al.
Publicado: (2002)

The influence of anti-cyclic citrullinated peptide on anticentromere antibody-positive rheumatoid arthritis patients
por: Jearn, La-He, et al.
Publicado: (2010)

Anti-cyclic citrullinated peptide antibody is a good indicator for the diagnosis of rheumatoid arthritis
por: Abdul Wahab, Asrul, et al.
Publicado: (2013)

Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis
por: Shibahara, Tomoya, et al.
Publicado: (2016)

Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
por: Al-Shukaili, Ahmed, et al.
Publicado: (2012)

To stop or not to stop: what should we be doing with biologic DMARDs when patients undergo orthopaedic surgery?
por: van Duren, Bernard H, et al.
Publicado: (2021)

Patients with checkpoint inhibitor‐induced inflammatory arthritis do not become seropositive for anti‐cyclic citrullinated peptide when followed over time
por: Cappelli, Laura C., et al.
Publicado: (2021)

Ability of second-generation anti-cyclic citrullinated peptide (CCP) to predict rheumatoid arthritis in patients with early arthritis
por: Saraux, A, et al.
Publicado: (2003)

‘It surprised me a lot that there is a link’: a qualitative study of the acceptability of periodontal treatment for individuals at risk of rheumatoid arthritis
por: Chapman, Lara S, et al.
Publicado: (2023)

Anti-Cyclic Citrullinated Peptide (Anti-CCP) and Anti-Mutated Citrullinated Vimentin (Anti-MCV) Relation with Extra-Articular Manifestations in Rheumatoid Arthritis
por: Gonzalez-Lopez, Laura, et al.
Publicado: (2014)

The anti-cyclic citrullinated peptide response in tuberculosis patients is not citrulline-dependent and sensitive to treatment
por: Elkayam, Ori, et al.
Publicado: (2010)

Identification of Natural Bispecific Antibodies against Cyclic Citrullinated Peptide and Immunoglobulin G in Rheumatoid Arthritis
por: Wang, Wei, et al.
Publicado: (2011)

Correlation of Anti-Cyclic Citrullinated Antibody with Hand Joint Erosion Score in Rheumatoid Arthritis Patients
por: Kim, Hyun Hee, et al.
Publicado: (2010)

Anti-Cyclic Citrullinated Peptide Antibody Is Associated with Interstitial Lung Disease in Patients with Rheumatoid Arthritis
por: Yin, Yufeng, et al.
Publicado: (2014)

Anti-Cyclic Citrullinated Peptide Antibodies and Severity of Interstitial Lung Disease in Women with Rheumatoid Arthritis
por: Rocha-Muñoz, Alberto Daniel, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g918iunjmh1cdm2emtroef59fn